Link
Respiratory syncytial virus: Canadian Immunization Guide
Organization: Public Health Agency of Canada (PHAC)Published: 2023
Respiratory syncytial virus (RSV) infection is a major cause of lower respiratory illness, particularly among infants, young children and older adults. In Canada, RSV causes yearly outbreaks of respiratory tract disease, usually starting in late fall and running through to early spring. Reinfections with RSV are common but illness is usually milder with subsequent infections. At present there is no vaccine available in Canada to prevent RSV. The only means of prevention is temporary passive protection with the monoclonal antibody preparation palivizumab (PVZ). PVZ contains antibody only against RSV.
Resource Group:
Implementation Tool
Product Type: Guide
Program Delivery and Evaluation
Clinics
Monitoring and Surveillance
Outbreaks and Pandemics
Outbreaks
Product Type: Guide
Category:
Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Monitoring and Surveillance,Outbreaks and Pandemics,Outbreaks Program Planning and DeliveryProgram Delivery and Evaluation
Clinics
Monitoring and Surveillance
Outbreaks and Pandemics
Outbreaks
Region:
National
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.